Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler

AstraZeneca

Status: Completed

Conditions: Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT00524641

NIS-RVN-SYM-2007/1

NIS-R84-AST-2007/3

Details and patient eligibility

About

To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6 weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.

Enrollment: 1,254 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Asthma patients from both sexes, age 18 or older
• Have already been on Symbicort SMART treatment
• Willing to give written informed consents to participate in the program.

Exclusion criteria

• Patients who are not willing to give written informed consent
• Patients in emergency care for asthma at ICUs or COPD patients are excluded from the program.